Investors

investor people image

Press Releases

Date Title and Summary Additional Formats
Toggle Summary Osiris Provides Update Regarding NASDAQ Listing Matters View HTML
Toggle Summary Peer-reviewed Publication on the use of Grafix® in High-Risk Peripheral Arterial Disease Patients with Treatment Refractory Ulcerations Demonstrating Durable Wound Closure View HTML
Toggle Summary Osiris Provides Update Regarding NASDAQ Listing Matters View HTML
Toggle Summary Osiris Therapeutics, Inc. Reports Preliminary 2014 and 2015 Revenue and Anticipated 2016 Revenue View HTML
Toggle Summary Peer-reviewed Publication on the use of Grafix® Prime for Outpatient Management of Complex Wounds with Exposed Bone, Tendon, Muscle, Joint, and Hardware View HTML
Toggle Summary Grafix® Cost Comparative Manuscript Reporting Wound Care Cost Reduction is Available Electronically in a Peer-Reviewed Journal View HTML
Toggle Summary Osiris to Present Clinical and Scientific Studies at Desert Foot 2016
Experts to host a variety of presentations at Desert Foot Conference, October 19 - 22, 2016, in Phoenix, Arizona
View HTML
Toggle Summary Net Health and Osiris Therapeutics Announce the Broad Availability of Grafix® to Wound Care Patients Due to WoundExpert® EMR Integration View HTML
Toggle Summary Osiris to Present Clinical and Scientific Studies at Symposium on Advanced Wound Care (SAWC)
Experts to host a variety of presentations at Symposium on Advanced Wound Care, October 07 - 09, 2016, in Las Vegas, Nevada
View HTML
Toggle Summary Osiris Therapeutics Announces Appointment of Alberto Avendano, M.D. as Chief Medical Officer View HTML